YolTech Therapeutics will participate in BIO-Europe 2025, taking place in Vienna, Austria. The annual conference brings together global leaders across biotechnology and pharmaceutical sectors, fostering collaboration and innovation in drug discovery and development. Dr. Alexandre Moreau, Global Strategic Advisor of YolTech Therapeutics, will deliver a company presentation during the event.
Dr. Moreau will discuss YolTech’s continued progress in developing transformative in vivo gene-editing therapies and an expanding clinical portfolio, highlighting the company’s vision for global growth and strategic partnerships.
Date: Monday, November 3, 2025
Time: 13:45–14:00 (CET)
Venue: Vienna Congress and Convention Center, Presenting Company Theater 1
LATESTNEWS
-
YolTech Announces Interim Clinical Data from Investigator-Initiated Trials of YOLT-203 in Primary Hyperoxaluria Type 1 to be Presented at the American Society of Nephrology (ASN) Kidney Week 2026
Oct 23, 2026
-
YolTech Appoints Nitin Patel, BM BCh, as U.S. Chief Medical Officer
Oct 14, 2026
-
YolTech Presented Proof-of-Concept Data from Clinical Trial of YOLT-202 in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026
Sep 07, 2026
